User: Guest  Login
Title:

The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical C

Document type:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Article
Author(s):
Jaguszewski, Milosz; Aloysius, Romila; Wang, Wei; Bezerra, Hiram G; Hill, Jonathan; De Winter, Robbert J; Karjalainen, Pasi P; Verheye, Stefan; Wijns, William; Lüscher, Thomas F; Joner, Michael; Costa, Marco; Landmesser, Ulf
Abstract:
The aim of the present study was to evaluate vascular healing of the bioengineered COMBO Dual Therapy Stent compared with a cobalt-chromium (CoCr) everolimus-eluting stent (EES) as assessed by optical coherence tomography in patients with acute coronary syndromes.CD34+ cells promote endothelial repair after vascular injury. The bioengineered COMBO Dual Therapy Stent combines CD34+ cell-capturing technology with abluminal sirolimus release, but more data from clinical studies evaluating the vascu...     »
Journal title abbreviation:
JACC Cardiovasc Interv
Year:
2017
Journal volume:
10
Journal issue:
5
Pages contribution:
489-499
Language:
eng
Fulltext / DOI:
doi:10.1016/j.jcin.2016.11.040
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/28279316
Print-ISSN:
1936-8798
TUM Institution:
Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter (Prof. Schunkert)
 BibTeX